Professor Saad Shakir on the gap in public knowledge about routine drug safety and pharmacovigilance activity It’s natural for people to enquire about a new drug or vaccine. Even more so when some ...

“We were very, very concerned that there (was) a lot of need, and little available for professional services -- particularly mental health services,” says psychiatrist Dr. Saad Shakir. Seeing all the ...

Professor Saad Shakir, the longstanding director of the Drug Safety Research Unit (DSRU) based in Southampton, has declared his resignation. He made the announcement on Monday, July 15 and his ...

Professor Shakir, director of the Drug Safety Research Unit, explains the cytokine storm, a major killer in patients with severe COVID-19 infection Professor Shakir, director of the Drug Safety ...

Saad Shakir (one of the investigators) comments: “Our results suggest that family doctors are five times more likely to report serious events on black-triangle drugs than non-serious labelled ...

It does not necessarily reflect the view of The Herald. Professor Saad Shakir, the longstanding director of the Drug Safety Research Unit (DSRU) based in Southampton, has declared his resignation.

Our group, TMS of Silicon Valley was founded by Dr. Saad Shakir with offices from San Jose to our northern most site in Corte Madera. We are unusual because we focus on TMS & nasal Esketamine ...

Dr. Saad Shakir leads CPR, or Care Program for Refugees. At first, CPR's goal was to give direct mental health care to Syrian refugees, but after seeing the overwhelming number of people needing ...

Prof. Saad Shakir, director of the Drug Safety Research Unit in the United Kingdom, describes the research as “hypothesis testing.” He was not involved in the study. He agrees that PPIs and ...